ARCHIVES

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

This article is from The Cancer Letter archive.

Vol. 31 No. 01 | January 7, 2005

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI CTEP Last Month

February 25, 2011

Peters Replaced As Director Of Karmanos Cancer Center.

December 1, 2000

Breast surgeon and advocate Susan Love weds surgeon Helen Cooksey in San Francisco.

February 20, 2004

Children’s Oncology Group Study Shows Improved Care For Childhood Brain Tumors

October 31, 2008

Senate Approves FY08 Labor-HHS Appropriations.

October 26, 2007

Rall Says NTP Must Have New Positions To Spend Extra $23 Million On Testing More Chemicals

September 7, 1979